Ms Michele Tait:

It was an observation at the time. The audit was conducted over the period to the end of 2017. At that stage and for quite a significant amount of time prior to us publishing a national screening guideline on hepatitis C, while we had a lot of hepatitis C screening taking place, we did not have a national guideline. The point that is being made in the chapter is that we did not have a national approach to screening, though screening was taking place. Now we do have a national guideline for screening in the form of a screening guideline that was published in 2017.